Literature DB >> 15135661

Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.

Sherif F Nagueh1, Suetnee Chen, Rajnikant Patel, Natalia Tsybouleva, Silvia Lutucuta, Helen A Kopelen, William A Zoghbi, Miguel A Quiñones, Robert Roberts, A J Marian.   

Abstract

Hypertrophic cardiomyopathy (HCM), the most common cause of sudden cardiac death in the young, is characterized by a diverse array of cardiac phenotypes evolving over several decades. We have developed transgenic rabbits that fully recapitulate the phenotype of human HCM and provide for the opportunity to delineate the sequence of evolution of cardiac phenotypes, and thus, the pathogenesis of HCM. We determined evolution of biochemical, molecular, histological, structural and functional phenotypes at 4 age-periods in 47 beta-myosin heavy chain-glutamine (MyHC-Q)-403 transgenic rabbits. Ca(+2) sensitivity of myofibrillar ATPase activity was reduced very early and in the absence of other discernible phenotypes. Myocyte disarray also occurred early, prior to, and independent of hypertrophy and fibrosis. The latter phenotypes evolved predominantly during puberty in conjunction with activation of stress-related signaling kinases. Myocardial contraction and relaxation velocities were decreased early despite normal global cardiac function and in the absence of histological phenotype. Global cardiac function declined with aging, while left atrial size was increased along with Doppler indices of left ventricular filling pressure. Thus, Ca(+2) sensitivity of myofibrillar ATPase activity is a primary phenotype expressed early and independent of the ensuing phenotypes. Pathogenesis of myocyte disarray, which exhibits age-independent penetrance, differs from those of hypertrophy and fibrosis, which show age-dependent expression. Myocardial dysfunction is an early marker that predicts subsequent development of hypertrophy. These findings in an animal model that recapitulates the phenotype of human HCM, implicate involvement of multiple independent mechanisms in the pathogenesis of cardiac phenotypes in HCM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135661      PMCID: PMC2768620          DOI: 10.1016/j.yjmcc.2004.02.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

Review 1.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy.

Authors:  S F Nagueh; L L Bachinski; D Meyer; R Hill; W A Zoghbi; J W Tam; M A Quiñones; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

Review 3.  Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

Authors:  Orlando F Bueno; Jeffery D Molkentin
Journal:  Circ Res       Date:  2002-11-01       Impact factor: 17.367

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.

Authors:  A M Varnava; P M Elliott; N Mahon; M J Davies; W J McKenna
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

6.  Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  R Patel; S F Nagueh; N Tsybouleva; M Abdellatif; S Lutucuta; H A Kopelen; M A Quinones; W A Zoghbi; M L Entman; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

7.  Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival.

Authors:  H Oh; G E Taffet; K A Youker; M L Entman; P A Overbeek; L H Michael; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

8.  Molecular mechanics of mouse cardiac myosin isoforms.

Authors:  Norman R Alpert; Christine Brosseau; Andrea Federico; Maike Krenz; Jeffrey Robbins; David M Warshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10       Impact factor: 4.733

Review 9.  Molecular mechanisms of inherited cardiomyopathies.

Authors:  Diane Fatkin; Robert M Graham
Journal:  Physiol Rev       Date:  2002-10       Impact factor: 37.312

10.  Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats.

Authors:  Fabrice Prunier; Roger Gaertner; Liliane Louedec; Jean-Baptiste Michel; Jean-Jacques Mercadier; Brigitte Escoubet
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

View more
  19 in total

Review 1.  Role of animal models in HCM research.

Authors:  Rhian Shephard; Christopher Semsarian
Journal:  J Cardiovasc Transl Res       Date:  2009-08-07       Impact factor: 4.132

Review 2.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

Review 3.  Beta-adrenergic receptors signaling and heart failure in mice, rabbits and humans.

Authors:  A J Marian
Journal:  J Mol Cell Cardiol       Date:  2006-05-23       Impact factor: 5.000

4.  Modeling human disease phenotype in model organisms: "It's only a model!".

Authors:  Ali J Marian
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

Review 5.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 6.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

7.  Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.

Authors:  Raffaella Lombardi; Achim Bell; Vinitha Senthil; Jasvinder Sidhu; Michela Noseda; Robert Roberts; Ali J Marian
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

Review 8.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

9.  Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy.

Authors:  Weihua Song; Petr G Vikhorev; Mavin N Kashyap; Christina Rowlands; Michael A Ferenczi; Roger C Woledge; Kenneth MacLeod; Steven Marston; Nancy A Curtin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

10.  Enhanced transmural fiber rotation and connexin 43 heterogeneity are associated with an increased upper limit of vulnerability in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  Crystal M Ripplinger; Wenwen Li; Jennifer Hadley; Junjie Chen; Florence Rothenberg; Raffaella Lombardi; Samuel A Wickline; Ali J Marian; Igor R Efimov
Journal:  Circ Res       Date:  2007-09-20       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.